VALBIOTIS est membre de Lyonbiopôle

General information

12F, Rue Paul Vatine

17180 Périgny

Incorporated in: 2018/09/10

Number of employees: 35

More information


Main activity

VALBIOTIS is a French Research & Development company committed to scientific innovation for preventing and combating metabolic diseases. Its products are made for manufacturers in the agri-food and pharmaceutical industries. VALBIOTIS particularly focuses on solutions to prevent type 2 diabetes, NASH (nonalcoholic steatohepatitis), obesity and cardiovascular diseases. VALBIOTIS was founded in La Rochelle in early 2014 and has formed numerous partnerships with top academic centers in France and abroad, including the La Rochelle University, the CNRS and the Clermont Auvergne University located in Clermont-Ferrand. These partnerships have enabled VALBIOTIS to benefit from strong financial leverage, particularly thanks to experts and technical partners who support its projects. The Company is now located on 3 sites in France – Périgny, La Rochelle (17) and Riom (63) – and has an American office in Boston (MA). VALBIOTIS is a member of the “BPI Excellence” network and received the “Innovative Company” status accorded by BPI France. VALBIOTIS has also been awarded “Young Innovative Company” status and has received major financial support from the European Union for its research programs by obtaining support from the European Regional Development Fund (ERDF).


Looking for funding: Yes

Stock exchange listing: Listed on the Stock Exchange on Euronext Growth since 2017

Products / Services / Technologies

Strategic area of application
Human Medicine

Application market
Metabolic Diseases

Nutrition & Health products